Clinical Microbiology
SKU
MRR-4312A385A416
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 7.80 billion
2030
USD 16.12 billion
2024
USD 8.68 billion
CAGR
10.91%

Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Global Forecast 2024-2030

[181 Pages Report] The Clinical Microbiology Market size was estimated at USD 7.80 billion in 2023 and expected to reach USD 8.68 billion in 2024, at a CAGR 10.91% to reach USD 16.12 billion by 2030.

Clinical Microbiology Market
To learn more about this report, request a free PDF copy

Clinical microbiology encompasses a wide range of testing methods, and it is complex in terms of organisms and methods used to isolate & identify them. Clinical microbiology investigates microorganisms that cause infectious diseases and focuses on isolating and characterizing infectious organisms such as bacteria, viruses, parasites, and fungi to manage and treat patients. The increasing occurence of infectious diseases, growing awareness of disease prevention, and increasing healthcare expenditure are all factors driving the use of clinical microbiology. Problems concerning quality assurance and management in clinical microbiology laboratories coupled with limited availability of equipment and infrastructure can pose a challenge to product penetration in the market. Additionally, technological advancement in clinical microbiology instruments and processes presents various opportunities for medical laboratory businesses to expand their portfolio and increase profitability.

Clinical Microbiology Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Product: Use of laboratory instruments in clinical microbiology assessments

Laboratory instruments such as incubators, biosafety cabinets, centrifuges, and microscopes include a wide scope of applications in clinical microbiology assessments. Clinical microbiologists prefer specialized reagents & analyzers to culture, detect, visualize, and identify microscopic organisms such as bacteria, archaea, viruses, fungi, or protozoa. Clinical reagents & analyzers aid in studying the morphology, structure, classification, genetic variation, physiology, and biochemistry of microorganisms for rapid clinical diagnostics.

Specimen Type: Preference for serum samples in serological testing to detect past or current infections

Blood specimens are essential for detecting bloodborne pathogens responsible for sepsis, endocarditis, and other systemic infections. Body fluids such as pleural, peritoneal, or pericardial fluid are crucial for diagnosing infections in serous cavities. CSF specimens are critical in diagnosing central nervous system infections, including meningitis or encephalitis. Fecal specimens are crucial for diagnosing gastrointestinal infections and monitoring antimicrobial resistance in enteric pathogens. Saliva specimens have gained attention in recent years as non-invasive alternatives to traditional methods for diagnosing respiratory infections, including COVID-19. Serum samples are essential for serological testing to detect past or current infections by measuring pathogen-specific antibodies.

End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions

Clinical microbiology assessments are performed at clinical laboratories, hospitals & care providers, and academic & research institutes to isolate and characterize infectious organisms for diagnosing disease conditions effectively. Laboratories and research institutes provide detailed insights regarding infectious disease conditions to healthcare professionals using clinical microbiology techniques.

Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens

Autoimmune diseases, including rheumatoid arthritis and lupus, involve the immune system attacking healthy cells. Clinical microbiology helps diagnose these conditions by identifying specific autoantibodies or inflammatory markers. Cardiology applications in clinical microbiology include diagnosing infections that affect the cardiovascular system, such as endocarditis and myocarditis. Rapid identification of pathogens enables targeted treatment and improved outcomes. Clinical microbiology plays a role in diabetes management by identifying infections that may impact blood glucose control or cause complications, such as urinary tract infections or foot ulcers infected by bacteria such as Staphylococcus aureus. In drug testing, clinical microbiology monitors antimicrobial resistance patterns to ensure appropriate therapeutic choices for infectious disease treatment. Clinical microbiology contributes to diagnosing gastrointestinal (GI) diseases by identifying causative pathogens, such as Helicobacter pylori or Clostridioides difficile. Nephrology-focused microbiology tests diagnose kidney-related infections, such as pyelonephritis, which requires specific antimicrobial therapies. Oncology applications within clinical microbiology involve diagnosing cancer-related infections that can compromise treatment plans or contribute to complications. In periodontal diseases, clinical microbiology helps dentists identify oral pathogens responsible for conditions such as gingivitis and periodontitis, enabling appropriate treatment selection.

Regional Insights

In North America, the strong presence of leading market players, increasing investments in research & development, and the growing prevalence of infectious diseases significantly increase the adoption of clinical microbiology. Highly developed pharmaceutical and healthcare sectors in the United States are fueling the adoption of advanced clinical diagnostic techniques. Developing new and innovative microbiological technologies, such as targeted polymerase chain reactions (PCRs), to increase cost-effectiveness and improve clinical outcomes is strengthening the market growth of clinical microbiology across the region. In Asia-Pacific, the growing popularity of broad-range and molecular diagnosis to surge the sensitivity of diagnosis while promoting time effectiveness significantly contributes to the development of clinical microbiology. The booming medical tourism industry is expected to increase the need for microbial diagnostic and monitoring tests in Asian countries such as India, China, Thailand, and Malaysia. In the Europe region, the increasing prevalence of pathogenic diseases, growth in the discovery of adapting bacterium, and the rising need for speedy microbiological testing methods enhance the utilization of clinical microbiology technology.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Microbiology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Microbiology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Wichita State’s MDL Lab Shifting To Microbiology.

    Wichita State University's Microbial Detection Laboratory (MDL) is set to shift its focus toward clinical microbiology to meet the growing demands of the healthcare industry. This new direction aligns with the MDL's core competencies, which includes the identification and control of microbial contaminants in food, water, and air. By expanding its expertise in clinical microbiology, the MDL is able to provide comprehensive testing and diagnostics for infectious diseases, in addition to its existing services. The laboratory's commitment to quality and precision sets it apart from others in the industry, making it a go-to resource for healthcare providers in need of reliable and efficient testing. This new development is a testament to the MDL's adaptability and commitment. [Published On: 2023-04-06]

  • Cambridge Start-Up Won Funding To Develop New Diagnostics.

    A Cambridge-based start-up company secured funding to develop advanced diagnostic tools for clinical microbiology. With the aim of revolutionizing the way bacterial infections are diagnosed and treated, the team of scientists and engineers at this innovative start-up are working toward creating a range of rapid and accurate tests that can identify and characterize infections in a few hours. With the potential to significantly improve patient outcomes and reduce the spread of antibiotic-resistant strains of bacteria, this development marks an exciting breakthrough for the field of clinical microbiology. [Published On: 2023-03-20]

  • Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore

    The Microbiology Society and the Indian Institute of Science (IISc) Bangalore have recently announced a groundbreaking Publish and Read agreement to enable open-access publishing to microbiologists worldwide, promoting knowledge sharing and enhancing researcher visibility and reputation. [Published On: 2023-03-16]

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Instruments, LLC, Agilent Technologies, Inc., B. Braun SE, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux S.A., Cardinal Health, Inc., Clinichem Ltd., COPAN Diagnostics Inc., Diagnóstica Longwood S.L., ELITech Group, F. Hoffmann-La Roche Ltd., Hardy Diagnostics, HORIBA, Ltd., Kyokuto Pharmaceutical Industrial Co., Ltd., Laboratorios Conda, S.A., Liofilchem S.r.l., Merck KGaA, Prestige Diagnostics U.K. Ltd., Pro Lab Diagnostics Inc., QIAGEN N.V., Rapid Micro Biosystems, Inc., Shimadzu Corporation, SSI Diagnostica A/S, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Vircell S.L..

Market Segmentation & Coverage

This research report categorizes the Clinical Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents
  • Specimen Type
    • Blood
    • Body fluids
    • Cerebrospinal Spinal Fluid
    • Fecal
    • Saliva
    • Serum
    • Synovial Fluid
    • Urine
  • End-User
    • Academic & Research Institutes
    • Hospitals & Care Providers
    • Laboratories
  • Application
    • Autoimmune Diseases
    • Cardiology
    • Diabetes
    • Drug Testing
    • Gastrointestinal Diseases
    • Nephrology
    • Oncology
    • Periodontal Diseases
    • Respiratory Diseases
    • Sexually Transmitted Diseases

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Clinical Microbiology Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Microbiology Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Microbiology Market?
  4. What is the market share of the leading vendors in the Clinical Microbiology Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Microbiology Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Increasing use of clinical microbiology in managing and controlling infectious diseases
        2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
      2. Restraints
        1. Limited availability of skilled professionals, equipment and infrastructure
      3. Opportunities
        1. Technological advancement in clinical microbiology products and processes
        2. Introduction of point-of-care microbiology testing
      4. Challenges
        1. Problems concerning quality assurance and management in clinical microbiology laboratories
    2. Market Segmentation Analysis
      1. Product: Use of laboratory instruments in clinical microbiology assessments
      2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
      3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
      4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
    3. Market Trend Analysis
      1. Presence of well-established market vendors with the ongoing development of advanced clinical microbiology testings
      2. Prevalence of infectious disease and improvements in clinical microbiology products in APAC
      3. Supportive government initiatives and ongoing research to overcome the burden of infectious diseases in the EMEA region
    4. Cumulative Impact of Russia-Ukraine Conflict
    5. Cumulative Impact of High Inflation
    6. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    7. Value Chain & Critical Path Analysis
    8. Regulatory Framework
  6. Clinical Microbiology Market, by Product
    1. Introduction
    2. Instruments
    3. Reagents
  7. Clinical Microbiology Market, by Specimen Type
    1. Introduction
    2. Blood
    3. Body fluids
    4. Cerebrospinal Spinal Fluid
    5. Fecal
    6. Saliva
    7. Serum
    8. Synovial Fluid
    9. Urine
  8. Clinical Microbiology Market, by End-User
    1. Introduction
    2. Academic & Research Institutes
    3. Hospitals & Care Providers
    4. Laboratories
  9. Clinical Microbiology Market, by Application
    1. Introduction
    2. Autoimmune Diseases
    3. Cardiology
    4. Diabetes
    5. Drug Testing
    6. Gastrointestinal Diseases
    7. Nephrology
    8. Oncology
    9. Periodontal Diseases
    10. Respiratory Diseases
    11. Sexually Transmitted Diseases
  10. Americas Clinical Microbiology Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific Clinical Microbiology Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  12. Europe, Middle East & Africa Clinical Microbiology Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  13. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
      1. Wichita State’s MDL Lab Shifting To Microbiology.
      2. Cambridge Start-Up Won Funding To Develop New Diagnostics.
      3. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
      4. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
      5. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
      6. ASM Funded for Inclusive Microbiology Leaders Program.
      7. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomérieux to Optimize Laboratory Workflow and Improve Patient Care.
      8. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
      9. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
      10. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
      11. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
      12. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
      13. Federal Funds Set To Boost U of A’s Ability To Handle Highly Infectious Pathogens.
      14. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
      15. Sci-Tech Daresbury’s Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
      16. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
      17. ValitaCell Joins Beckman Coulter Life Sciences.
      18. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
      19. SSI Diagnostica Continues a Strong Growth Journey.
      20. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
      21. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
      22. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
      23. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
      24. bioMérieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
      25. NIH Funded New Tuberculosis Research Advancement Centers.
      26. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
      27. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
      28. Hardy Diagnostics Now Offers the BioCode MDx-3000.
      29. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
      30. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.
  14. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  15. List of Figures [Total: 24]
    1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
    2. CLINICAL MICROBIOLOGY MARKET SIZE, 2023 VS 2030
    3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
    7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
    10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    16. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    18. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    22. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    23. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
    24. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Tables [Total: 398]
    1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD MILLION)
    31. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    32. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    33. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
    34. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
    35. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
    36. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
    37. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
    38. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
    39. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    40. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    41. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
    42. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
    43. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
    44. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
    45. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
    46. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
    47. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2023 (USD MILLION)
    48. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2024-2030 (USD MILLION)
    49. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
    50. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
    51. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
    52. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
    53. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
    54. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
    55. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
    56. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
    57. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
    58. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
    59. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2023 (USD MILLION)
    60. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2024-2030 (USD MILLION)
    61. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    62. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    63. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    64. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    65. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    66. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    67. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    68. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    69. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    70. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    71. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    72. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    73. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    74. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    75. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    76. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    77. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    78. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    79. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    80. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    81. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    82. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    83. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    84. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    85. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    86. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    87. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    88. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    89. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    90. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    91. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    92. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    93. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    94. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    95. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    96. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    97. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    98. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    99. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    100. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    101. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    102. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    103. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    104. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    105. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    106. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    107. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    108. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    109. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    110. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    111. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    112. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    113. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    114. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    115. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    116. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    117. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    118. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    119. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    120. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    121. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    122. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    123. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    124. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    125. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    126. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    127. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    128. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    129. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    130. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    131. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    132. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    133. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    134. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    135. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    136. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    137. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    138. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    139. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    140. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    141. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    142. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    143. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    144. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    145. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    146. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    147. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    148. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    149. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    150. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    151. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    152. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    153. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    154. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    155. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    156. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    157. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    158. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    159. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    160. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    161. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    162. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    163. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    164. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    165. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    166. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    167. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    168. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    169. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    170. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    171. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    172. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    173. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    174. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    175. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    176. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    177. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    178. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    179. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    180. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    181. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    182. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    183. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    184. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    185. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    186. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    187. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    188. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    189. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    190. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    191. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    192. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    193. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    194. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    195. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    196. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    197. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    198. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    199. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    200. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    201. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    202. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    203. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    204. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    205. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    206. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    207. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    208. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    209. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    210. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    211. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    212. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    213. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    214. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    215. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    216. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    217. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    218. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    219. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    220. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    221. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    222. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    223. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    224. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    225. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    226. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    227. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    228. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    229. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    230. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    231. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    232. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    233. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    234. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    235. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    236. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    237. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    238. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    239. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    240. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    241. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    242. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    243. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    244. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    245. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    246. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    247. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    248. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    249. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    250. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    251. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    252. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    253. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    254. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    255. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    256. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    257. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    258. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    259. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    260. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    261. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    262. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    263. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    264. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    265. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    266. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    267. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    268. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    269. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    270. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    271. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    272. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    273. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    274. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    275. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    276. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    277. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    278. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    279. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    280. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    281. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    282. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    283. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    284. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    285. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    286. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    287. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    288. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    289. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    290. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    291. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    292. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    293. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    294. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    295. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    296. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    297. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    298. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    299. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    300. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    301. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    302. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    303. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    304. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    305. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    306. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    307. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    308. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    309. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    310. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    311. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    312. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    313. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    314. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    315. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    316. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    317. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    318. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    319. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    320. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    321. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    322. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    323. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    324. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    325. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    326. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    327. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    328. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    329. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    330. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    331. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    332. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    333. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    334. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    335. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    336. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    337. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    338. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    339. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    340. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    341. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    342. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    343. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    344. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    345. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    346. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    347. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    348. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    349. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    350. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    351. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    352. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    353. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    354. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    355. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    356. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    357. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    358. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    359. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    360. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    361. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    362. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    363. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    364. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    365. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    366. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    367. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    368. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    369. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    370. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    371. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    372. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    373. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    374. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    375. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    376. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    377. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    378. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    379. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    380. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    381. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    382. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    383. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    384. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    385. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    386. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    387. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    388. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    389. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    390. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    391. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
    392. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
    393. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    394. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    395. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    396. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    397. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
    398. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  17. List of Companies Mentioned [Total: 30]
    1. 3M Company
    2. Abbott Laboratories
    3. Advanced Instruments, LLC
    4. Agilent Technologies, Inc.
    5. B. Braun SE
    6. Beckman Coulter, Inc.
    7. Becton, Dickinson and Company
    8. Bio-Rad Laboratories, Inc.
    9. bioMérieux S.A.
    10. Cardinal Health, Inc.
    11. Clinichem Ltd.
    12. COPAN Diagnostics Inc.
    13. Diagnóstica Longwood S.L.
    14. ELITech Group
    15. F. Hoffmann-La Roche Ltd.
    16. Hardy Diagnostics
    17. HORIBA, Ltd.
    18. Kyokuto Pharmaceutical Industrial Co., Ltd.
    19. Laboratorios Conda, S.A.
    20. Liofilchem S.r.l.
    21. Merck KGaA
    22. Prestige Diagnostics U.K. Ltd.
    23. Pro Lab Diagnostics Inc.
    24. QIAGEN N.V.
    25. Rapid Micro Biosystems, Inc.
    26. Shimadzu Corporation
    27. SSI Diagnostica A/S
    28. TCS Biosciences Ltd.
    29. Thermo Fisher Scientific Inc.
    30. Vircell S.L.
Microbial Detectives: Solving Medical Mysteries with Clinical Microbiology
September 11, 2023
INSIGHT
Microbial Detectives: Solving Medical Mysteries with Clinical Microbiology
Clinical microbiology has undergone vital revelations with the rise of molecular biology techniques and laboratory automation, emerging as a powerful realm to manage infectious diseases, guide treatment decisions, and safeguard public health.

Clinical microbiology is the bedrock of accurate disease diagnosis as it identifies the culprits behind infections and builds tailored and effective therapies for their treatment. This concept is making strides to unlock progress in personalized medicine by understanding how a person’s unique microbial makeup influences their health.

Computers and clinical laboratory scientists have worked together to offer optimal efficiency and quality in clinical microbiology laboratory activities to improve patient care. Becton, Dickinson and Company, COPAN Diagnostics, and Illumina, Inc. are some major companies using artificial intelligence (AI) to interpret bacterial growth and release negative specimens with minimal human interaction.

Numerous agencies and initiatives are working on supporting the development of clinical microbiology capacity in low-resource settings with government funding and investment. Governments and research institutes are bringing quality clinical microbiology made at a population level through well-functioning reference laboratory networks for effective antimicrobial resistance surveillance.

In the coming years, there will be a better focus on bringing more rapid diagnosis for new threats from infectious microorganisms, such as agents of bioterrorism and emerging pathogens, while equally favoring increased standardization of testing. Clinical microbiology is the world’s compass in leading the healthcare industry towards a safer future, where microbes are not just adversaries but partners in progress.

How Clinical Microbiology is used to Manage and Control Infectious Diseases
June 26, 2023
BLOG
How Clinical Microbiology is used to Manage and Control Infectious Diseases
Clinical microbiology is the branch of medical science that deals with the diagnosis and treatment of infectious diseases caused by bacteria, viruses, fungi, and parasites. It plays a crucial role in managing and controlling infectious diseases, especially in the current times of increasing outbreaks. With the advancements in technology, clinical microbiology has become more sophisticated, allowing quicker and more accurate detection and identification of pathogens. This blog post will explore the ways clinical microbiology is used to manage and control infectious diseases.

Diagnosis of Infectious Diseases:

One of the primary uses of clinical microbiology is the diagnosis of infectious diseases. The identification of the causative agent, be it bacteria or virus, helps determine the appropriate treatment options. The laboratory tests include the culture of microorganisms, examination of body fluids or tissues under the microscope, and serological tests. Rapid diagnostic tests have also been developed to identify the presence of specific pathogens, helping diagnose the disease earlier and enabling better infection control measures to be implemented.

Antibiotic Resistance:

Antibiotic resistance is becoming a global concern, with bacterial resistance to antibiotics increasing each year. Clinical microbiology plays a significant role in understanding and controlling antibiotic resistance. Microbiology labs perform susceptibility testing on bacterial samples to determine the appropriate antibiotics that can help treat the infection. This helps prevent the overuse of broad-spectrum antibiotics, leading to the development of antibiotic-resistant strains.

Outbreak Control:

Clinical microbiology is also involved in controlling infectious disease outbreaks by identifying the source of infection. Identifying the specific strain of the infectious agent can determine the source of infection and how it is being spread. This information helps with the prevention of further infections, and timely interventions can be initiated to mitigate the spread of the disease.

Epidemiology:

Clinical microbiology studies how infectious diseases spread and evolve over time. This helps in understanding the transmission patterns of the disease, which is useful in developing appropriate control measures. Epidemiological investigations provide information on how to target the disease, identify populations at risk, and the most effective interventions.

Monitoring of Health Trends:

Clinical microbiology is essential for monitoring the prevalence of infectious diseases. Surveillance systems are in place to detect the occurrence, distribution, and trends of infections. This information guides policymakers in developing public health measures such as vaccination campaigns and the allocation of resources for infectious disease control.

Clinical microbiology is an integral part of managing and controlling infectious diseases. With the advancements in technology, clinical microbiology has become more sophisticated, enabling quicker and more accurate detection and identification of pathogens. Through the diagnosis of infectious diseases, understanding and controlling antibiotic resistance, outbreak control, epidemiology, and monitoring of health trends, clinical microbiology has a significant impact on infectious disease management. The continued advancements in this field play a crucial role in mitigating infectious disease threats and improving global health outcomes.

Frequently Asked Questions
  1. How big is the Clinical Microbiology Market?
    Ans. The Global Clinical Microbiology Market size was estimated at USD 7.80 billion in 2023 and expected to reach USD 8.68 billion in 2024.
  2. What is the Clinical Microbiology Market growth?
    Ans. The Global Clinical Microbiology Market to grow USD 16.12 billion by 2030, at a CAGR of 10.91%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.